Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Kick off an IRA with zero-commission index funds, focusing on cost-effective options and straightforward fund selection.
17,840 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Polymarket faced a rapid POL drain on May 22, 2026, but the team said the issue was an internal wallet breach, not a ...
A gas explosion at a Shanxi coal mine has killed 82 and injured 120+, triggering a national safety probe as regulator...
Global stablecoins have surged to a record $322 billion, underscoring a fast-moving shift in payments and prompting c...
A major hedge fund exit grabbed headlines as a fund controlled by William Oberndorf liquidated a sizable monday.com s...
If the CLARITY Act clears Congress, crypto assets could be reclassified into three buckets, altering enforcement, lis...
A new Harvard Law study analyzes whether a safety-focused mission can survive investor pressure as Anthropic prepares...
A new income model uses a $560,000 portfolio built from covered-call ETFs, preferred shares, and BDCS to generate abo...
A 70-year-old aims to generate $69,600 a year from a $1.1 million portfolio, testing whether higher-yield income stra...
Tilray shifted from cannabis focus to a BrewDog partnership in search of diversification. But early UK sales data rai...
Whales are stepping in to buy the dip as Dogecoin dips to a 14-month low. On-chain data shows a notable uptick in lar...
The next five years could redefine SpaceX’s place in markets from launches to internet services. This guide breaks do...